Literature DB >> 2565853

The complete nucleotide sequence of the glutamine synthetase gene (glnA) of Bacillus subtilis.

Y Nakano1, E Tanaka, C Kato, K Kimura, K Horikoshi.   

Abstract

The glutamine synthetase (GS) gene from Bacillus subtilis PCI 219 was cloned in Escherichia coli using the vector pBR329. A plasmid, pSGS2, was isolated from a glnA+ transformant and the cloned GS gene was found to be located in a 3.6 kb DNA fragment. The nucleotide sequence of a 1.8 kb segment encoding the GS was determined. This segment showed an open reading frame which would encode a polypeptide of 444 amino acids. The amino acid sequence of this GS gene product has higher homology with that of the Clostridium acetobutylicum GS than that of the E. coli GS.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2565853     DOI： 10.1016/0378-1097(89)90151-1

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN： 0378-1097            Impact factor:   2.742


  4 in total

1.  Cloning and nucleotide sequence of an archaebacterial glutamine synthetase gene: phylogenetic implications.

Authors:  A M Sanangelantoni; D Barbarini; G Di Pasquale; P Cammarano; O Tiboni
Journal:  Mol Gen Genet       Date:  1990-04

2.  The Bacillus subtilis sigL gene encodes an equivalent of sigma 54 from gram-negative bacteria.

Authors:  M Débarbouillé; I Martin-Verstraete; F Kunst; G Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

3.  Cloning and sequencing of the gene encoding glutamine synthetase I from the archaeum Pyrococcus woesei: anomalous phylogenies inferred from analysis of archaeal and bacterial glutamine synthetase I sequences.

Authors:  O Tiboni; P Cammarano; A M Sanangelantoni
Journal:  J Bacteriol       Date:  1993-05       Impact factor: 3.490

4.  An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets.

Authors:  G Harth; M A Horwitz
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.